Clovis Oncology Presents Efficacy and Safety Data from New Drug Application (NDA) Population for Rucaparib in the Treatment of Advanced Mutant BRCA Ovarian Cancer at 2016 ESMO Congress
Go back to Clovis Oncology Presents Efficacy and Safety Data from New Drug Application (NDA) Population for Rucaparib in the Treatment of Advanced Mutant BRCA Ovarian Cancer at 2016 ESMO Congress| CLOVIS ONCOLOGY (NASDAQ: CLVS) | Delayed: 0.08 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.08 | 52 Week High | $40.29 | |||
| Open | $3.48 | 52 Week Low | $11.57 | |||
| Day High | $0.08 | P/E | N/A | |||
| Day Low | $0.08 | EPS | $-2.82 | |||
| Volume | 282,973 | |||||
| Roche Holding AG Basel American Depositary Shares (AMEX: RHHBY) | Delayed: 49.42 -0.32 (0.64%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $49.74 | 52 Week High | $35.13 | |||
| Open | $49.06 | 52 Week Low | $28.10 | |||
| Day High | $49.44 | P/E | N/A | |||
| Day Low | $49.00 | EPS | $0.00 | |||
| Volume | 1,725,038 | |||||
| Brown & Brown, Inc. (NYSE: RO) | Delayed: 8.49 +0.55 (6.93%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.94 | 52 Week High | $8.59 | |||
| Open | $7.94 | 52 Week Low | $7.82 | |||
| Day High | $8.59 | P/E | 6.53 | |||
| Day Low | $7.82 | EPS | $1.30 | |||
| Volume | 42,732 | |||||
